Display Settings:

Format

Send to:

Choose Destination

    Vaccine. 2008 Mar 28;26(15):1863-73. Epub 2008 Feb 20.

    Age-dependent tolerance to an endogenous tumor-associated antigen.

    McWilliams JA, Sullivan RT, Jordan KR, McMahan RH, Kemmler CB, McDuffie M, Slansky JE.

    Integrated Department of Immunology, University of Colorado Health Sciences Center, 1400 Jackson Street, Denver, CO 80206, United States.

    Immunologic tolerance to endogenous antigens reduces antitumor responses. Gp70 is an endogenous tumor-associated antigen (TAA) of the BALB/c-derived colon carcinoma CT26. We found that expression of gp70 mRNA is detectable in tissues of mice 8 months of age and older. We showed that expression of gp70 establishes immunologic tolerance and affects antitumor immunity in a similarly age-dependent manner using gp70-deficient mice. We found that tumors grew in all gp70-sufficient mice, while approximately half of gp70-deficient mice controlled tumor growth with endogenous T-cell responses. Protection in gp70-deficient mice correlated with more robust gp70-specific CTL responses, and increased numbers and avidity of responding antigen-specific T cells after vaccination. We conclude that immunosurveillance may decline with age due to increased or de novo peripheral expression of endogenous TAAs.

    PMID: 18329760 [PubMed - indexed for MEDLINE]

    PMCID: 2295286

    Supplemental Content

    Click here to read Click here to read Click here to read